Easy derivatisation of group 10 N-heterocyclic carbene complexes and in vitro evaluation of an anticancer oestradiol conjugate

ChemPlusChem

Volumn 77, Issue 11, 2012, Pages 1028-1038

  Chardon, Edith ^a,b   Puleo, Gian Luigi ^a   Dahm, Georges ^a   Fournel, Sylvie ^a   Guichard, Gilles ^b   Bellemin Laponnaz, Stéphane ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Antitumor agents; Carbenes; Cycloaddition; Nitrogen heterocycles; Platinum

Indexed keywords

EID: 84869044843     PISSN: None     EISSN: 21926506     Source Type: Journal    
DOI: 10.1002/cplu.201200092     Document Type: Article

References (93)

1. B. Rosenberg, L. VanCamp, T. Krigas, Nature 1965, 205, 698-699.
2. a) T. W. Hambley, Coord. Chem. Rev. 1997, 166, 181-223
3. b) E. Wong, C. M. Giandomenico, Chem. Rev. 1999, 99, 2451-2466
4. c) R. B. Weiss, M. C. Christian, Drugs 1993, 46, 360-377.
5. P. J. O'Dwyer, J. P. Stevenson, S. W. Johnson, in Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drug (Ed.: B. Lippert), Wiley-VCH, Weinheim, 1999, pp. 3-27.
6. W. Hu, Q. Luo, K. Wu, X. Li, F. Wang, Y. Chen, X. Ma, J. Wang, J. Liu, S. Xiong, P. J. Sadler, Chem. Commun. 2011, 47, 6006-6008.
7. a) M. E. Palma, C. F. Weisea, C. Lundinb, G. Wingslec, Y. Nygrena, E. Björna, P. Naredib, M. Wolf-Watza, P. Wittung-Stafshedea, Proc. Natl. Acad. Sci. USA 2011, 108, 6951-6956
8. b) A. Alt, K. Lammens, C. Chiocchini, A. Lammens, J. C. Pieck, D. Kuch, K. P. Hopfner, T. Carell, Science 2007, 318, 967-970
9. c) Z. H. Siddik, Oncogene 2003, 22, 7265-7279.
10. For selected reviews, see: a) D. Bourissou, O. Guerret, F. P. Gabbai, G. Bertrand, Chem. Rev. 2009, 253, 862-892
11. b) V. César, S. Bellemin-Laponnaz, L. H. Gade, Chem. Soc. Rev. 2004, 33, 619-636
12. c) W. A. Herrmann, Angew. Chem. 2002, 114, 1342-1363
13. Angew. Chem. Int. Ed. 2002, 41, 1290-1309.
14. a) M. Skander, P. Retailleau, B. Bourri, L. Schio, P. Mailliet, A. Marinetti, J. Med. Chem. 2010, 53, 2146-2154
15. b) P. Mailliet, A. Marinetti, M. Skander, WO2009/118475, 2009.
16. S. Ray, R. Mohan, J. K. Singh, M. K. Samantaray, M. M. Shaikh, D. Panda, P. Ghosh, J. Am. Chem. Soc. 2007, 129, 15042-15053.
17. For reviews on the medicinal properties of metal-NHC complexes, see: a) A. Gautier, F. Cisnetti, Metallomics 2012, 4, 23-32
18. b) K. M. Hindi, M. J. Panzner, C. A. Tessier, C. L. Cannon, W.J. Youngs, Chem. Rev. 2009, 109, 3859-3884
19. c) M.-L. Teyssot, A.-S. Jarrousse, M. Manin, A. Chevry, S. Roche, F. Norre, C. Beaudoin, L. Morel, D. Boyer, R. Mahioue, A. Gautier, Dalton Trans. 2009, 6894-6902.
20. a) L. Mercs, M. Albrecht, Chem. Soc. Rev. 2010, 39, 1903-1912
21. b) N-Heterocyclic Carbenes: From Laboratory Curiosities to Efficient Synthetic Tools (Ed.: S. Dîez-Gonzéles), RSC Catalysis Series, Royal Society of Chemistry, Cambridge, UK, 2010.
22. a) J. Lemke, A. Pinto, P. Niehoff, V. Vasylyeva, N. Metzler-Nolte, Dalton Trans. 2009, 7063-7070
23. b) U. E. I. Horvath, G. Bentivoglio, M. Hummel, H. Schottenberger, K. Wurst, M.J. Nell, C. E.J. van Rensburg, S. Cronje, H. G. Raubenheimer, New J. Chem. 2008, 32, 533-539.
24. For selected examples of post-functionalisation of complexes, see: a) M. Patra, N. Metzler-Nolte, Chem. Commun. 2011, 47, 11444-11446
25. b) L. Raszeja, A. Maghnouj, S. Hahn, N. Metzler-Nolte, ChemBioChem 2011, 12, 371-376
26. c) J. Zagermann, K. Klein, K. Merz, M. Molon, N. Metzler-Nolte, Eur. J. Inorg. Chem. 2011, 4212-4219
27. d) V. César, N. Lugan, G. Lavigne, Chem. Eur. J. 2010, 16, 11432-11442
28. e) L. Benhamou, N. Vujkovic, V. César, H. Gornitzka, N. Lugan, G. Lavigne, Organometallics 2010, 29, 2616-2630
29. f) D. Urankar, J. Košmrlj, Inorg. Chim. Acta 2010, 363, 3817-3822
30. g) F. Noor, R. Kinscherf, G. A. Bonaterra, S. Walczak, S. Wölfl, N. Metzler-Nolte, ChemBioChem 2009, 10, 493-502
31. h) H. Pfeiffer, A. Rojas, J. Niesel, U. Schatzschneider, Dalton Trans. 2009, 4292-4298
32. i) L. Benhamou, V. César, H. Gornitzka, N. Lugan, G. Lavigne, Chem. Commun. 2009, 4720-4722
33. j) D. Samanta, K. Kratz, X. Zhang, T. Emrick, Macromolecules 2008, 41, 530-532
34. k) S. Fukuzawa, H. Oki, M. Hosaka, J. Sugasawa, S. Kikuchi, Org. Lett. 2007, 9, 5557-5560.
35. For a preliminary account, see: E. Chardon, G. L. Puleo, G. Dahm, G. Guichard, S. Bellemin-Laponnaz, Chem. Commun. 2011, 47, 5864-5866.
36. T. M. V. D. Pinho e Melo in Organic Azides: Syntheses and Applications (Eds.: S. Bräse, K. Banert), Wiley, Chichester, 2010.
37. For a review on the alternative routes to NHC precursors, see: L. Benhamou, E. Chardon, G. Lavigne, S. Bellemin-Laponnaz, V. César, Chem. Rev. 2011, 111, 2705-2733.
38. C. Bruneau, P. H. Dixneuf, Acc. Chem. Res. 1999, 32, 311-323.
39. A.M. Oertel, V. Ritleng, M.J. Chetcuti, Synthesis 2009, 10, 1647-1650.
40. The 1H NMR spectrum of complex 3 shows a similar signal pattern to that of complexes reported in the literature: a) R. Jothibasu, K.-W. Huang, H.V. Huynh, Organometallics 2010, 29, 3746
41. b) J. Pytkowicz, S. Roland, P. Mangeney, G. Meyer, A. Jutand, J. Organomet. Chem. 2003, 678, 166-179.
42. During the reaction, less than 5% of the cis isomers was formed, which was easily removed by chromatography on silica gel because they were more polar than the trans isomers.
43. a) L. Ray, M. M. Shaikh, P. Ghosh, Organometallics 2007, 26, 958-964
44. b) A. J. Boydston, J. D. Rice, M. D. Sanderson, O. L. Dykhno, C. W. Bielawski, Organometallics 2006, 25, 6087-6098
45. c) M. Frøseth, K. A. Netland, H.W. Törnroos, A. Dhindsa, M. Tilset, Dalton Trans. 2005, 1664-1674
46. d) L. G. Bonnet, R. E. Douthwaite, R. Hodgson, J. Houghton, B. M. Kariuki, S. Simonovic, Dalton Trans. 2004, 3528-3535
47. e) C. J. O'Brien, E. A. B. Kantchev, C. Valente, N. Hadei, G. A. Chass, A. Lough, A. C. Hopkinson, M. G. Organ, Chem. Eur. J. 2006, 12, 4743-4748.
48. In contrast to platinum, the monocarbenic complexes of palladium were experimentally demonstrated to be not robust enough to further support the TMS-deprotection conditions.
49. W. B. Cross, C. G. Daly, R. L. Ackerman, I. R. George, K. Singh, Dalton Trans. 2011, 40, 495-505.
50. Attempts to use other sources of amines as solvent/ligand such as cyclohexylamine to synthesise Pt-cyclohexylamine complex 6 directly from 2 led to the partial deprotection of the TMS group and afforded a mixture of polynuclear complexes. E. Chardon, G. L. Puleo, G. Dahm, G. Guichard, S. Bellemin-Laponnaz, unpublished results.
51. S. Bellemin-Laponnaz, E. Chardon, G. Guichard, Int. Patent WO 2012085479, 2012.
52. a) M. Meldal, C. W. Tornøe, Chem. Rev. 2008, 108, 2952-3015
53. b) C. W. Tornøe, C. Christensen, M. Meldal, J. Org. Chem. 2002, 67, 3057-3064
54. c) V. V. Rostovtsev, L. G. Green, V. V. Fokin, K. B. Sharpless, Angew. Chem. 2002, 114, 2708-2711
55. Angew. Chem. Int. Ed. 2002, 41, 2596-2599.
56. a) K. Osakada, M. Hamada, T. Yamamoto, Organometallics 2000, 19, 458-468
57. b) M. J. Irwin, G. Jia, J. J. Vittal, R. J. Puddephatt, Organometallics 1996, 15, 5321-5329
58. c) N. Hagihara, K. Sonogashira, S. Takahashi, Adv. Polym. Sci. 1981, 41, 149
59. d) S. Kotani, K. Shiina, K. Sonogashira, Appl. Organomet. Chem. 1991, 5, 417-425
60. e) K. Sonogashira, S. Kataoka, S. Takahashi, N. Hagihara, J. Organomet. Chem. 1978, 160, 319-327
61. f) N. Ohshiro, F. Takei, K. Onituska, S. Takahashi, J. Organomet. Chem. 1998, 569, 195-202.
62. a) L. Zhang, X. Chen, P. Xue, H. H. Y Sun, I. D. Williams, K. B. Sharpless, V. V. Fokin, G. Jia, J. Am. Chem. Soc. 2005, 127, 15998-15999
63. b) B. C. Boren, S. Narayan, L. K. Rasmussen, L. Zhang, H. Zhao, Z. Lin, G. Jia, V. V. Fokin, J. Am. Chem. Soc. 2008, 130, 8923-8930
64. c) L. K. Rasmussen, B. C. Boren, V. V. Fokin, Org. Lett. 2007, 9, 5337-5339.
65. a) M. McClellan, J. Benner, R. Schilsky, D. Epstein, R. Woosley, S. Friend, D. Sidransky, C. Geoghegan, D. Kessler, Nat. Rev. Drug Discovery 2011, 10, 79-80
66. b) K. Malinowsky, C. Wolff, S. Gündisch, D. Berg, K. F Becker, J. Cancer 2011, 2, 26-35
67. c) C. Sawyers, Nature 2004, 432, 294-297.
68. a) E. K. Shanle, W. Xu, Adv. Drug Delivery Rev. 2010, 62, 1265-1276
69. b) B. Deroo, K. S. Korach, J. Clin. Invest. 2006, 116, 561-570
70. c) N. Heldring, A. Pike, S. Andersson, J. Matthews, G. Cheng, J. Hartman, M. Tujague, A. Strom, E. Treuter, M. Warner, J. A. Gustafsson, Physiol. Rev. 2007, 87, 905-931.
71. a) S. Top, H. E. Hafa, A. Vessieres, J. Quivy, J. Vaissermann, D.W. Hughes, M.J. McGlinchy, J. P. Moron, E. Thoreau, G. Jaouen, J. Am. Chem. Soc. 1995, 117, 8372-8380
72. b) V. Gagnon, M.-E. St-Germain, C. Descteaux, J. Provencher-Mandeville, S. Parent, S. K. Mandal, E. Asselin, G. Bérubé, Bioorg. Med. Chem. Lett. 2004, 14, 5919-5924
73. c) M.J. Hannon, P.S. Green, D. M. Fisher, P. J. Derrick, J. L. Beck, S. J. Watt, S. F. Ralph, M. M. Sheil, PR. Barker, N.W. Alcock, R.J. Price, K.J. Sanders, R. Pither, J. Davis, A. Rodger, Chem. Eur. J. 2006, 12, 8000-8013.
74. C. Descôteaux, J. Provencher-Mandeville, I. Mathieu, V. Perron, S. K. Mandal, E. Asselina, G. Bérubé, Bioorg. Med. Chem. Lett. 2003, 13, 3927-3954.
75. +), see: a) K. A. Jackson, G. Oprea, J. Handy, K. S. Kimbro, J. Ovarian Res. 2009, 2, 15-21
76. b) D. Faratian, A. J. M. Zweemer, Y Nagumo, A. H. Sims, M. Muir, M. Dodds, P. Mullen, I. Um, C. Kay, M. Hasmann, D.J. Harrison, S. P. Langdon, Clin. Cancer Res. 2011, 17, 4451-4461
77. c) P. J. Hughes, LE. Twist, J. Durham, M. A. Choudhry, M. Drayson, R. Chandraratna, R. H. Michell, C. J. Kirk, G. Brown, Biochem. J. 2001, 355, 361-371
78. d) G. Fiorelli, L. Picariello, V. Martineti, F. Tonelli, M. L. Brandi, Biochem. Biophys. Res. Commun. 1999, 261, 521-527
79. e) I. Y Kim, B.-C. Kim, D. H. Seong, D. K. Lee, J.-M. Seo, H.J. Hong, H.-T. Kim, R. A. Morton, S.-J. Kim, Cancer Res. 2002, 62, 5365-5369
80. -, see:
81. g) Ref. [31 f]
82. h) Z. Kocsis, Z. L. Marcsek, M. G. Jakab, B. Szende, A. Tompa, Int. J. Hyg. Environ. Health 2005, 208, 211-218.
83. S. Singh, C. Paraskeva, P. H. Gallimore, M. C. Sheppard, M. J. S. Langman, Anticancer Res. 1994, 14, 1037-1041.
84. a) F. May-Levin, F. Guerinot, G. Contesso, J. C. Delarue, C. Bohuon, Int. J. Cancer 1977, 19, 789-795
85. b) W. L. McGuire, Annu. Rev. Med. 1975, 26, 353-363.
86. a) D. Lyden, K. Hattori, S. Dias, C. Costa, P. Blaikie, L. Butros, A. Chardburn, B. Heissig, W. Marks, L. Witte, Y. Wu, D. Hicklin, Z. Zhu, N. R. Hackett, R. G. Crystal, M. A. Moore, K. A. Hajjar, K. Manova, R. Benezra, S. Rafii, Nat. Med. 2001, 7, 1194-1201
87. b) F Bertolini, S. Paul, P. Mancuso, S. Monestiroli, A. Gobbi, Y Shaked, R. S. Kerbel, Cancer Res. 2003, 63, 4342-4346
88. c) A. Orimo, P. B. Gupta, D. C. Sgroi, F. Arenzana-Seisdedos, T. Delaunay, R. Naeem, V.J. Carey, A. L. Richardson, R. A. Weinberg, Cell 2005, 121, 335-348.
89. a) J. Provencher-Mandeville, C. Debnath, S. K. Mandal, V. Leblanc, S. Parent, E. Asselin, G. Bérubé, Steroids 2011, 76, 94-103
90. b) A. M. Otto, M. Faded, H. Schönenberger, Cancer Res. 1991, 51, 3217-3223
91. c) J. Karl, R. Gust, T. Spruss, M. R. Schneider, H. Schönenberg, J. Engel, K. H. Wrobel, F. Lux, S. T. Haeberlin, J. Med. Chem. 1988, 31, 72-83.
92. E. D. Goddard-Borger, R. V. Stick, Org. Lett. 2007, 9, 3797-3800.
93. CCDC-856303 (4) and CCDC-856304 (6) contain the supplementary crystallographic data for this paper. These data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data- request/cif.